Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 073 (Cinacalcet) in Secondary Hyperparathyroidism on Hemodialysis
NCT00527267Phase 3Completed
- Sponsor
- Amgen
- Start
- Feb 2002
- Primary completion
- Apr 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Amgen. Started Feb 2002; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00527267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527267.